Cannabidiol and 5-HT1A Receptors

Neuropathology of Drug Addictions and Substance Misuse

Volumn 1, Issue , 2016, Pages 749-759

  Fogaça, Manoela V ^a   Campos, Alline C ^a   Guimarães, Francisco S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

5HT1A receptors; Anxiety; Cannabidiol; Cannabis sativa; Depression; Motor control; Nausea; Neuroprotection; Phytocannabinoids; Serotonin

Indexed keywords

EID: 84969594450     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-800213-1.00070-5     Document Type: Chapter

References (74)

1. Adams, R. (1941). Marihuana. Harvey Lectures, 37, 168-197.
2. Alves, F. H., Crestani, C. C., Gomes, F. V., Guimarães, F. S., Correa, F. M., & Resstel, L. B. (2010). Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors. Pharmacological Research, 62(3), 228-236.
3. Bambico, F. R., Cassano, T., Dominguez-Lopez, S., Katz, N., Walker, C. D., Piomelli, D., & Gobbi, G. (2010). Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus. Neuropsychopharmacology, 35(10), 2083-2100.
4. Bevilaqua, L., Ardenghi, P., Schroder, N., Bromberg, E., Schmitz, P. K., Schaeffer, E., ... Izquierdo, I. (1997). Drugs acting upon the cyclic adenosine monophosphate/protein kinase A signalling pathway modulate memory consolidation when given late after training into rat hippocampus but not amygdala. Behavioural Pharmacology, 8(4), 331-338.
5. Bisogno, T., Hanus, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., ... Di Marzo, V. (2001). Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. British Journal of Pharmacology, 134(4), 845-852.
6. Blier, P., Pineyro, G., el Mansari, M., Bergeron, R., & de Montigny, C. (1998). Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Annals of the New York Academy of Sciences, 861, 204-216.
7. Campos, A. C., & Guimarães, F. S. (2008). Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berlin), 199(2), 223-230.
8. Campos, A. C., & Guimarães, F. S. (2009). Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 33(8), 1517-1521.
9. Campos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012). Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors. Journal of Psychiatric Research, 46(11), 1501-1510.
10. Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012). Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philosophical Transactions of the Royal Society, Series B, Biological Sciences, 367(1607), 3364-3378.
11. Campos, A. C., Ortega, Z., Palazuelos, J., Fogaça, M. V., Aguiar, D. C., Diaz-Alonso, J., ... Guimarães, F. S. (2013). The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. International Journal of Neuropsychopharmacology, 16(6), 1407-1419.
12. Campos, A. C., de Paula Soares, V., Carvalho, M. C., Ferreira, F. R., Vicente, M. A., Brandão, M. L., ... Guimarães, F. S. (2013). Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats. Psychopharmacology (Berlin), 226(1), 13-24.
13. Casarotto, P. C., Gomes, F. V., Resstel, L. B., & Guimarães, F. S. (2010). Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors. Behavioural Pharmacology, 21(4), 353-358.
14. Cassano, T., Gaetani, S., Macheda, T., Laconca, L., Romano, A., Morgese, M. G., ... Piomelli, D. (2011). Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacology (Berlin), 214(2), 465-476.
15. Cloëz-Tayarani, I., Kayyali, U. S., Fanburg, B. L., & Cavaillon, J. M. (2004). 5-HT activates ERK MAP kinase in cultured-human peripheral blood mononuclear cells via 5-HT1A receptors. Life Science, 76(4), 429-443.
16. Crippa, J. A., Hallak, J. E., Machado-de-Sousa, J. P., Queiroz, R. H., Bergamaschi, M., Chagas, M. H., & Zuardi, A. W. (2013). Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report. Journal of Clinical Pharmacy and Therapeutics, 38(2), 162-164.
17. De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., ... Di Marzo, V. (2011). Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. British Journal of Pharmacology, 163(7), 1479-1494.
18. De Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P. C., Orlando, P., & Di Marzo, V. (2008). Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. Journal of Pharmacology and Experimental Therapeutics, 325(3), 1007-1015.
19. Espejo-Porras, F., Fernández-Ruiz, J., Pertwee, R. G., Mechoulam, R., & García, C. (2013). Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. Neuropharmacology, 75, 155-163.
20. Esposito, G., Scuderi, C., Valenza, M., Togna, G. I., Latina, V., De Filippis, D., ... Steardo, L. (2011). Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARgamma involvement. PLoS One, 6(12), e28668.
21. Fernandez-Ruiz, J., Sagredo, O., Pazos, M. R., Garcia, C., Pertwee, R., Mechoulam, R., & Martinez-Orgado, J. (2013). Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? British Journal of Clinical Pharmacology, 75(2), 323-333.
22. Fogaça, M. V., Aguiar, D. C., Moreira, F. A., & Guimarães, F. S. (2012). The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior. Neuropharmacology, 63(2), 202-210.
23. Fogaça, M. V., Galve-Roperh, I., Guimarães, F. S., & Campos, A. C. (2013). Cannabinoids, neurogenesis and antidepressant drugs: is there a link? Current Neuropharmacology, 11(3), 263-275.
24. Fogaça, M. V., Gomes, F. V., Moreira, F. A., Guimarães, F. S., & Aguiar, D. C. (2013). Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats. Psychopharmacology (Berlin), 226(3), 579-587.
25. Fogaça, M. V., Reis, F. M., Campos, A. C., & Guimarães, F. S. (2014). Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. European Neuropsychopharmacology, 24(3), 410-419.
26. Franklin, J. M., & Carrasco, G. A. (2013). Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT2A) receptor activity via ERK1/2 signaling. Synapse, 67(3), 145-159.
27. Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2013). Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 46, 43-47.
28. Gomes, F. V., Reis, D. G., Alves, F. H., Corrêa, F. M., Guimarães, F. S., & Resstel, L. B. (2012). Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors. Journal of Psychopharmacology, 26(1), 104-113.
29. Gomes, F. V., Resstel, L. B., & Guimarães, F. S. (2011). The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors. Psychopharmacology (Berlin), 213(2-3), 465-473.
30. Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990). Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berlin), 100(4), 558-559.
31. Hayakawa, K., Mishima, K., Nozako, M., Ogata, A., Hazekawa, M., Liu, A. X., ... Fujiwara, M. (2007). Repeated treatment with cannabidiol but not delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance. Neuropharmacology, 52(4), 1079-1087.
32. Hojo, M., Sudo, Y., Ando, Y., Minami, K., Takada, M., Matsubara, T., & Uezono, Y. (2008). mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis. Journal of Pharmaceutical Sciences, 108(3), 308-319.
33. Jenny, M., Santer, E., Pirich, E., Schennach, H., & Fuchs, D. (2009). Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro. Journal of Neuroimmunology, 207(1-2), 75-82.
34. Kathmann, M., Flau, K., Redmer, A., Tränkle, C., & Schlicker, E. (2006). Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Naunyn-Schmiedeberg's Archives of Pharmacology, 372(5), 354-361.
35. Katsidoni, V., Anagnostou, I., & Panagis, G. (2013). Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus. Addiction Biology, 18(2), 286-296.
36. Liou, G. I., Auchampach, J. A., Hillard, C. J., Zhu, G., Yousufzai, B., Mian, S., ... Khalifa, Y. (2008). Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. Investigative Ophthalmology & Visual Science, 49(12), 5526-5531.
37. Ludanyi, A., Eross, L., Czirjak, S., Vajda, J., Halasz, P., Watanabe, M., ... Katona, I. (2008). Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. Journal of Neuroscience, 28(12), 2976-2990.
38. Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R., & Berry, E. M. (2010). Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation. British Journal of Pharmacology, 159(4), 950-957.
39. Mahgoub, M., Keun-Hang, S. Y., Sydorenko, V., Ashoor, A., Kabbani, N., Al Kury, L., ... Oz, M. (2013). Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors. European Journal of Pharmacology, 720(1-3), 310-319.
40. Marco, E. M., Garcia-Gutierrez, M. S., Bermudez-Silva, F. J., Moreira, F. A., Guimarães, F., Manzanares, J., & Viveros, M. P. (2011) Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. Frontiers in Behavioral Neuroscience 5, 63.
41. Mechoulam, R., & Shvo, Y. (1963). The structure of cannabidiol. Tetrahedron, 19, 2073-2078.
42. Mishima, K., Hayakawa, K., Abe, K., Ikeda, T., Egashira, N., Iwasaki, K., & Fujiwara, M. (2005). Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke, 36(5), 1077-1082.
43. Morgan, C. J., Das, R. K., Joye, A., Curran, H. V., & Kamboj, S. K. (2013). Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. Addictive Behaviors, 38(9), 2433-2436.
44. O'Sullivan, S. E., Sun, Y., Bennett, A. J., Randall, M. D., & Kendall, D. A. (2009). Time-dependent vascular actions of cannabidiol in the rat aorta. European Journal of Pharmacology, 612(1-3), 61-68.
45. Pandolfo, P., Silveirinha, V., dos Santos-Rodrigues, A., Venance, L., Ledent, C., Takahashi, R. N., ... Kofalvi, A. (2011). Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum. European Journal of Pharmacology, 655(1-3), 38-45.
46. Parker, L. A., Burton, P., Sorge, R. E., Yakiwchuk, C., & Mechoulam, R. (2004). Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Psychopharmacology (Berlin), 175(3), 360-366.
47. Parker, L. A., Kwiatkowska, M., & Mechoulam, R. (2006). Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: an animal model of anticipatory nausea and vomiting. Physiology & Behavior, 87(1), 66-71.
48. Pazos, M. R., Mohammed, N., Lafuente, H., Santos, M., Martínez-Pinilla, E., Moreno, E., ... Martínez-Orgado, J. (2013). Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT1A and CB2 receptors. Neuropharmacology, 71, 282-291.
49. Peroutka, S. J., & Snyder, S. H. (1979). Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Molecular Pharmacology, 16(3), 687-699.
50. Przybyla, J. A., & Watts, V. J. (2010). Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers. Journal of Pharmacology and Experimental Therapeutics, 332(3), 710-719.
51. Qin, N., Neeper, M. P., Liu, Y., Hutchinson, T. L., Lubin, M. L., & Flores, C. M. (2008). TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. Journal of Neuroscience, 28(24), 6231-6238.
52. Ren, Y., Whittard, J., Higuera-Matas, A., Morris, C. V., & Hurd, Y. L. (2009). Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. Journal of Neuroscience, 29(47), 14764-14769.
53. Resstel, L. B., Tavares, R. F., Lisboa, S. F., Joça, S. R., Corrêa, F. M., & Guimarães, F. S. (2009). 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. British Journal of Pharmacology, 156(1), 181-188.
54. Risinger, F. O., & Boyce, J. M. (2002). 5-HT1A receptor blockade and the motivational profile of ethanol. Life Science, 71(6), 707-715.
55. Rock, E. M., Bolognini, D., Limebeer, C. L., Cascio, M. G., Anavi-Goffer, S., Fletcher, P. J., ... Parker, L. A. (2012). Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus. British Journal of Pharmacology, 165(8), 2620-2634.
56. Rock, E. M., Goodwin, J. M., Limebeer, C. L., Breuer, A., Pertwee, R. G., Mechoulam, R., & Parker, L. A. (2011). Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. Psychopharmacology (Berlin), 215(3), 505-512.
57. Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005). Agonistic properties of cannabidiol at 5-HT1A receptors. Neurochemical Research, 30(8), 1037-1043.
58. Ryan, D., Drysdale, A. J., Pertwee, R. G., & Platt, B. (2006). Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia. Neuroscience Letters, 408(3), 236-241.
59. Scopinho, A. A., Guimarães, F. S., Corrêa, F. M., & Resstel, L. B. (2011). Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists. Pharmacology Biochemistry and Behavior, 98(2), 268-272.
60. Soares Vde, P., Campos, A. C., Bortoli, V. C., Zangrossi, H., Jr., Guimarães, F. S., & Zuardi, A. W. (2010). Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors. Behavioural Brain Research, 213(2), 225-229.
61. Stern, C. A., Gazarini, L., Takahashi, R. N., Guimarães, F. S., & Bertoglio, L. J. (2012). On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Neuropsychopharmacology, 37(9), 2132-2142.
62. Takahashi, K. A., & Castillo, P. E. (2006). The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience, 139(3), 795-802.
63. Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007). Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. British Journal of Pharmacology, 150(5), 613-623.
64. Thompson, P. M., Cruz, D. A., Olukotun, D. Y., & Delgado, P. L. (2012). Serotonin receptor, SERT mRNA and correlations with symptoms in males with alcohol dependence and suicide. Acta Psychiatrica Scandinavica, 126(3), 165-174.
65. Todd, A. R. (1946). Hashish. Experientia, 2, 55-60.
66. Tominaga, M., Caterina, M. J., Malmberg, A. B., Rosen, T. A., Gilbert, H., Skinner, K., ... Julius, D. (1998). The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron, 21(3), 531-543.
67. Twardowschy, A., Castiblanco-Urbina, M. A., Uribe-Mariño, A., Biagioni, A. F., Salgado-Rohner, C. J., Crippa, J. A., & Coimbra, N. C. (2013). The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae). Journal of Psychopharmacology, 27(12), 1149-1159.
68. Wolf, S. A., Bick-Sander, A., Fabel, K., Leal-Galicia, P., Tauber, S., Ramirez-Rodriguez, G., ... Kempermann, G. (2010) Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Cell Communication and Signaling 8, 12.
69. Xing, J., & Li, J. (2007). TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl-PAG) neurons. Journal of Neurophysiology, 97(1), 503-511.
70. Xiong, W., Koo, B. N., Morton, R., & Zhang, L. (2011). Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism. Neuroscience, 16(184), 28-37.
71. Zanelati, T. V., Biojone, C., Moreira, F. A., Guimarães, F. S., & Joca, S. R. (2010). Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. British Journal of Pharmacology, 159(1), 122-128.
72. Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S. (1993). Effects of ipsapirone and cannabidiol on human experimental anxiety. Journal of Psychopharmacology, 7(Suppl. 1), 82-88.
73. Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982). Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology (Berlin), 76(3), 245-250.
74. Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H., Sorgard, M., Di Marzo, V., ... Hogestatt, E. D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400(6743), 452-457.